VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma

Although PD-1/PD-L1 blockade therapy confers salutary effects across cancer types, their efficacy in Extranodal Natural killer/T-cell lymphoma (ENKTCL) patients is limited and unpredictable. Here, we comprehensively evaluated the expression profile of a panel of immune-regulatory makers to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hai-Xia, Gao, Yan, Fu, Jian-Chang, Zhou, Qiang-Hua, Wang, Xiao-Xiao, Bai, Bing, Li, Peng-Fei, Huang, Cheng, Rong, Qi-Xiang, Ping, Li-Qin, He, Yan-Xia, Mao, Jia-Ying, Chen, Xu, Huang, Hui-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032243/
https://www.ncbi.nlm.nih.gov/pubmed/33889438
http://dx.doi.org/10.1080/2162402X.2021.1907059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032243/
https://www.ncbi.nlm.nih.gov/pubmed/33889438
http://dx.doi.org/10.1080/2162402X.2021.1907059

Ejemplares similares